MetabolomicsWorkbenchapplication/xmlhttp://www.metabolomicsworkbench.org/rest/study/study_id/ST001238/mwtabprimaryOK200MetabolomicsMass SpectrometryESIMalariaPlasmodium Falciparumhttp://www.metabolomicsworkbench.org/data/DRCCMetadata.php?Mode=Study&StudyID=ST001238Treatment:CXP18.6-017Treatment:MMV689258Treatment:CXP18.6-052Treatment:NoneTreatment:CXP18.6-026Plasmodium CellsPennsylvania State UniversityReversed phase NEGATIVE ION MODE/Orbitrap. Reversed phase NEGATIVE ION MODE/QTOF.MetabolomicsWorkbench4-phosphopantothenateCXP18.6-052MMV689258acetyl-CoApantothenateCXP18.6-017CXP18.6-026coenzyme ADrugs, treatment, Therapy, Products, Product, Pharmaceutic Preparations, drug, Metabonomic, Metabonomics, Treatments, Drug, Preparations, drugs, disease management., Therapeutic, medicine, Pharmaceutical, Pharmaceutical Product, Therapies, Treatment, Pharmaceutic, Preparation, Metabolomic, Pharmaceutical Products, Pharmaceutical Preparation, Pharmaceuticalsbackward, reversed., reversedfalseP falciparum asexual metabolomics following drug treatment (part-I)ST0012385833